Investment Thesis
BrightSpring demonstrates strong revenue growth (+28.2% YoY) and solid cash generation with $394.7M free cash flow, indicating operational execution in home healthcare services. However, thin profitability margins (1.5% net, 2.3% operating) and elevated leverage (1.34x D/E) with weak interest coverage (1.9x) suggest limited financial flexibility and vulnerability to operational disruptions.
Strengths
- Robust revenue growth of 28.2% YoY demonstrating market demand and expansion
- Strong free cash flow generation of $394.7M supporting capital allocation and debt service
- Solid current and quick ratios (1.57x and 1.12x) indicating adequate short-term liquidity
- Significant improvement in diluted EPS (+1066.7% YoY) showing operational leverage benefits
Risks
- Extremely thin net margin of 1.5% and operating margin of 2.3% leave minimal buffer for cost pressures or reimbursement changes
- High leverage with 1.34x D/E ratio and $2.5B long-term debt combined with weak 1.9x interest coverage ratio
- Low ROA (3.0%) and modest ROE (10.2%) relative to debt levels indicate inefficient capital deployment
- Home healthcare sector vulnerability to regulatory reimbursement changes and labor cost inflation
Key Metrics to Watch
- Operating margin expansion trajectory and ability to maintain pricing amid cost pressures
- Interest coverage ratio improvement and debt reduction progress
- Cash conversion rate and capital efficiency trends in organic growth investments
Financial Metrics
Revenue
12.9B
Net Income
190.7M
EPS (Diluted)
$0.87
Free Cash Flow
394.7M
Total Assets
6.4B
Cash
88.4M
Profitability Ratios
Gross Margin
11.8%
Operating Margin
2.3%
Net Margin
1.5%
ROE
10.2%
ROA
3.0%
FCF Margin
3.1%
Balance Sheet & Liquidity
Current Ratio
1.57x
Quick Ratio
1.12x
Debt/Equity
1.34x
Debt/Assets
70.6%
Interest Coverage
1.88x
Long-term Debt
2.5B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-21T15:42:10.055348 |
Data as of: 2025-12-31 |
Powered by Claude AI